<DOC>
	<DOCNO>NCT01344304</DOCNO>
	<brief_summary>The object study evaluate superiority aprepitant therapy 5HT3-receptor antagonist , dexamethasone aprepitant compare standard therapy 5HT3-receptor antagonist dexamethasone prevention nausea vomit first course chemotherapy .</brief_summary>
	<brief_title>Study Aprepitant / Fosaprepitant Prevention Chemotherapy-induced Nausea Vomiting ( CINV ) Colorectal Cancer Patients - SENRI Trial</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Age : ≥20 year old Sex : Not specify Patients colon/rectal cancer first underwent FOLFOX , XELOX SOX regimen include oxaliplatin ≥85 mg/m2 ( naive patient ) , already start chemotherapy nausea Grade 2 high last course earlier course ( nonnaive patient ) . Stage : specify ( neoadjuvant/adjuvant chemotherapy , advance recurrent type allow ) Combination molecular target therapy : allowable Written inform consent participation study . Severe liver kidney disease Nausea/vomiting within 24 hr prior chemotherapy . Treatment antiemetic within 24 hr prior chemotherapy . Presence factor cause nausea/vomiting chemotherapy ( e.g . brain tumor , gastrointestinal obstruction , active peptic ulcer disease , brain metastasis ) Presence disease preclude 3day administration dexamethasone ( e.g . uncontrollable diabetes ) Pregnant lactate woman , woman plan become pregnant . Current treatment pimozide . Any patient judge inappropriate study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>aprepitant therapy</keyword>
	<keyword>fosaprepitant therapy</keyword>
	<keyword>5HT3-receptor antagonist</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>FOLFOX</keyword>
	<keyword>XELOX</keyword>
	<keyword>SOX</keyword>
</DOC>